Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
doi: 10.1038/S41596-021-00560-Y 205 PagliucaFWMillmanJRGrtlerMSegelMVan DervortARyuJHet al
Preclinical investigations encompassing ethanol-induced gastric mucosal lesions, NSAID-mediated ulceration, cysteamine-induced duodenal injury, and inflammatory bowel disease analogues have reported associations between BPC157 exposure and reductions in mucosal lesion surface area, preservation of submucosal vascular architecture, and modulation of mucosal structural integrity
Even when the injury is not severe enough to require surgery, recovery can be slow, especially when tendons, ligaments, fascia, and other connective tissues are involved
Protective effects of -mangostin against acetaminophen-induced acute liver injury in mice
BPC-157 is a research-stage compound without the extensive Phase I, II, and III clinical trials that FDA-approved medications undergo
US$ 21.79
US$ 25.26
US$ 23.73
US$ 23.94
US$ 22.84
